SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech informs about revised earnings presentation

01 Jun 2022 Evaluate

With reference to its intimation dated May 31, 2022 regarding Earnings Presentation for Quarter 4- Financial Year 2021-2022, Fermenta Biotech has informed that there was a typographical error on page 6 – para 2 ‘Q4-FY22 Operational Highlights’ of the said Earnings Presentation. In view of above, the company has enclosed the revised Earnings Presentation for Quarter 4- Financial Year 2021-2022 for the record. Except the said revision on page 6- para 2 ‘Q4-FY22 Operational Highlights’, all other details remain unchanged. The revised Earnings Presentation will thereafter be uploaded on Company’s website at www.fermentabiotech.com.

The above information is a part of company’s filings submitted to BSE.


Fermenta Biotech Share Price

312.55 -9.30 (-2.89%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×